Figure 3.
MN for use in the treatment of coronary atherosclerosis and CVD intimal hyperplasia
(A) A drug-loaded balloon with a built NIR-controlled tip-separable MN for arteriosclerosis treatment. Adapted with permission.90 Copyright 2022, Elsevier.
(B) A sirolimus-embedded silk fibroin MN for neointimal hyperplasia treatment. Adapted with permission.92 Copyright 2023, Mdpi.
(C) An MN mesh can be wrapped around blood vessels for neointimal hyperplasia treatment. Adapted with permission.58 Copyright 2017, Elsevier.
(D) Highly flexible and porous silk fibroin MN for vascular intimal hyperplasia treatment. Adapted with permission.93 Copyright 2021, Elsevier.